id | C00001822 |
---|---|
Name | Boldine / d-Boldine |
CAS RN | 476-70-0 |
Standard InChI | InChI=1S/C19H21NO4/c1-20-5-4-10-7-15(22)19(24-3)18-12-9-16(23-2)14(21)8-11(12)6-13(20)17(10)18/h7-9,13,21-22H,4-6H2,1-3H3/t13-/m0/s1 |
Standard InChI (Main Layer) | InChI=1S/C19H21NO4/c1-20-5-4-10-7-15(22)19(24-3)18-12-9-16(23-2)14(21)8-11(12)6-13(20)17(10)18/h7-9,13,21-22H,4-6H2,1-3H3 |
Phytochemical cluster | No. 4 |
---|---|
KCF-S cluster | No. 20 |
By standard InChI | CHEMBL388342 |
---|---|
By standard InChI Main Layer | CHEMBL388342 CHEMBL1321247 CHEMBL1437753 |
By LinkDB | C09365 |
---|
By CAS RN | C011686 |
---|
class name | count |
---|---|
Magnoliophyta | 12 |
rosids | 1 |
family name | count |
---|---|
Lauraceae | 6 |
Monimiaceae | 2 |
Annonaceae | 2 |
Rhamnaceae | 1 |
Atherospermataceae | 1 |
Magnoliaceae | 1 |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL388342 CHEMBL1437753 |
CHEMBL1614110
(3)
CHEMBL1741321
(2)
|
1 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | CHEMBL1321247 |
CHEMBL1738312
(1)
|
0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | CHEMBL388342 |
CHEMBL2114784
(1)
|
1 / 1 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | CHEMBL1321247 |
CHEMBL1614076
(1)
|
1 / 1 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | CHEMBL1321247 |
CHEMBL1794585
(1)
|
0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | CHEMBL388342 |
CHEMBL1614544
(1)
|
11 / 10 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL388342 CHEMBL1437753 |
CHEMBL1614027
(1)
CHEMBL1741325
(2)
|
0 / 1 |
P17787 | Neuronal acetylcholine receptor subunit beta-2 | CHRN beta | CHEMBL388342 |
CHEMBL905461
(2)
|
1 / 1 |
P43681 | Neuronal acetylcholine receptor subunit alpha-4 | CHRN alpha | CHEMBL388342 |
CHEMBL905461
(2)
|
1 / 1 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | CHEMBL1321247 |
CHEMBL1614166
(2)
|
1 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL388342 CHEMBL1321247 CHEMBL1437753 |
CHEMBL1614458
(5)
|
0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | CHEMBL388342 CHEMBL1437753 |
CHEMBL1614456
(2)
CHEMBL1613803
(2)
|
0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | CHEMBL1321247 |
CHEMBL1794486
(1)
|
0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | CHEMBL1321247 |
CHEMBL1738606
(1)
|
0 / 0 |
O75496 | Geminin | Unclassified protein | CHEMBL388342 |
CHEMBL2114843
(1)
|
0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | CHEMBL1321247 |
CHEMBL2114788
(1)
|
0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | CHEMBL1321247 |
CHEMBL1794569
(1)
|
1 / 1 |
P36544 | Neuronal acetylcholine receptor subunit alpha-7 | CHRN alpha | CHEMBL388342 |
CHEMBL905460
(2)
|
0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL388342 CHEMBL1437753 |
CHEMBL1741322
(2)
|
0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | CHEMBL388342 CHEMBL1321247 CHEMBL1437753 |
CHEMBL1613910
(4)
CHEMBL1614227
(3)
|
3 / 3 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | CHEMBL388342 CHEMBL1321247 CHEMBL1437753 |
CHEMBL1614038
(4)
|
2 / 2 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | CHEMBL388342 CHEMBL1321247 |
CHEMBL1738588
(2)
CHEMBL1738317
(1)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL388342 CHEMBL1437753 |
CHEMBL1741323
(2)
|
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL388342 CHEMBL1321247 CHEMBL1437753 |
CHEMBL1614108
(3)
CHEMBL1613886
(3)
CHEMBL1741324 (2) |
0 / 1 |
Q9UNA4 | DNA polymerase iota | Enzyme | CHEMBL1321247 |
CHEMBL1794483
(1)
|
0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL1321247 |
CHEMBL1614211
(1)
|
0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL1321247 |
CHEMBL1614421
(2)
CHEMBL1614502
(2)
|
4 / 3 |
Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL1321247 |
CHEMBL1794536
(1)
|
0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | CHEMBL388342 CHEMBL1321247 |
CHEMBL1613914
(5)
|
0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL388342 |
CHEMBL1738442
(1)
|
0 / 0 |
O00255 | Menin | Unclassified protein | CHEMBL1321247 |
CHEMBL1614257
(2)
|
2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL1321247 |
CHEMBL1614257
(2)
|
1 / 3 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | CHEMBL1321247 |
CHEMBL1613933
(2)
|
0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | CHEMBL1321247 |
CHEMBL1613933
(2)
|
1 / 6 |
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#600513 | Epilepsy, nocturnal frontal lobe, 1; enfl1 |
P43681
|
#605375 | Epilepsy, nocturnal frontal lobe, 3; enfl3 |
P17787
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#232300 | Glycogen storage disease ii |
P10253
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | disease name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00807 | Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) |
P17787
(related)
P43681 (related) |
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|